InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,083.68
(
0.70%
)
US TECH 100
17,117.60
(
0.82%
)
Dow Jones
38,133.36
(
0.12%
)
Brent Oil
88.41
(
0.29%
)
Bitcoin
64,004.76
(
-0.74%
)
Post# of 7536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: kei post# 3094

Wednesday, 05/24/2017 1:06:11 PM

Wednesday, May 24, 2017 1:06:11 PM

Post# of 7536
TNXP "All we need to know this morning in 1 paragraph.

Quote:

The U.S. Patent and Trademark Office has issued a patent (U.S. Patent No. 9,636,408) protecting the composition and manufacture of the unique TNX-102 SL formulation. The Protectic™ protective eutectic and Angstro-Technology™ formulation claimed in the patent are important elements of Tonix’s proprietary TNX-102 SL composition. This patent is expected to provide TNX-102 SL with U.S. market exclusivity until 2034 upon NDA approval".
Posted by "Pres46" today.  

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up